Robertet SA has expanded its partnership with Aethera Biotech through a strategic investment to build a joint venture focused on plant-based biotechnology for cosmetic active ingredients. The deal combines Aethera’s patented CROP technology and production capabilities with Robertet’s global commercial network to develop and market sustainable, high-performance natural extracts, with the investment to be completed in two phases over three years under certain conditions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Robertet SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603060255OMX_____CNEWS_EN_GNW1001168562_en) on March 06, 2026, and is solely responsible for the information contained therein.
Comments